Newsroom Newsroom Press Releases Events & Presentations News Articles Media Center Recent Press Releases July 23, 2024 Frontier Medicines Announces Milestone Payment in AbbVie Partnership, Following Advancement of Lead Candidates Targeting a Historically Undruggable Transcription Factor View Release June 25, 2024 Frontier Medicines Appoints Gerardo Ubaghs as Chief Financial Officer and Announces $20 Million Series C Extension View Release April 9, 2024 Frontier Medicines Presents New Data for First-In-Class Dual ON+OFF KRAS G12C Inhibitor FMC-376 at the AACR Annual Meeting View Release Read All Press Releases Events & Presentations UPCOMING EVENTS There are currently no upcoming events scheduled Select Media Coverage April 11, 2024 Fierce Biotech: AACR: Verastem, Quanta and Frontier demonstrate KRAS inhibitors' potential in preclinical data Read Article February 22, 2024 Fierce Biotech: Frontier CEO weathers 'one of the hardest financings' of his career to close $80M series C Read Article February 22, 2024 San Francisco Business Times: Peninsula biotech raises $80M as it doses 1st person in 1st clinical trial Read Article Read All News Media Center Media Contact Contact PR Team Logos Click on the links below to download a high resolution image of the Frontier Medicines logo Download Image Download Image Download Image Download Image
July 23, 2024 Frontier Medicines Announces Milestone Payment in AbbVie Partnership, Following Advancement of Lead Candidates Targeting a Historically Undruggable Transcription Factor View Release
June 25, 2024 Frontier Medicines Appoints Gerardo Ubaghs as Chief Financial Officer and Announces $20 Million Series C Extension View Release
April 9, 2024 Frontier Medicines Presents New Data for First-In-Class Dual ON+OFF KRAS G12C Inhibitor FMC-376 at the AACR Annual Meeting View Release
April 11, 2024 Fierce Biotech: AACR: Verastem, Quanta and Frontier demonstrate KRAS inhibitors' potential in preclinical data Read Article
February 22, 2024 Fierce Biotech: Frontier CEO weathers 'one of the hardest financings' of his career to close $80M series C Read Article
February 22, 2024 San Francisco Business Times: Peninsula biotech raises $80M as it doses 1st person in 1st clinical trial Read Article